---
$id: https://graph.org.ai/products/commodity/51171931
$type: Product
source: UNSPSC
code: "51171931"
title: "Cetraxate"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cetraxate

**UNSPSC Code**: 51171931
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anxiolytic with the molecular formula C17H23NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5VPA8CPF0N, chemically known as hydrocinnamic acid, p-hydroxy-, 4-(aminomethyl)cyclohexanecarboxylate, trans- but generally known as cetraxate, which bears US NIH Compound Identifier 2680. European Medicines Agency schedules Cetraxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07457MIG. The term CETRAXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). CETRAXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cetraxate under HS 29224995 and SITC 51465. As of Q4 2014, CETRAXATE remains the US FDA Preferred Term for this commodity. Cetraxate bears US NLM identifiers UMLS ID C0055150 and NCI Concept Code C79885. SMILES: O(C(=O)C1CCC(CC1)CN)C1CCC(CC1)CCC(=O)O.

